Cargando…

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus

A clinical trial performed in the Democratic Republic of Congo (DRC), among persons with epilepsy (PWE) infected with Onchocerca volvulus treated with anti-seizure medication suggested that ivermectin reduces the seizure frequency. We assessed the effect of ivermectin treatment on seizure frequency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dusabimana, Alfred, Tsebeni Wafula, Solomon, Raimon, Stephen Jada, Fodjo, Joseph Nelson Siewe, Bhwana, Dan, Tepage, Floribert, Abd-Elfarag, Gasim, Hotterbeekx, An, Abrams, Steven, Colebunders, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824398/ https://www.ncbi.nlm.nih.gov/pubmed/33396221 http://dx.doi.org/10.3390/pathogens10010021

Ejemplares similares

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo
por: Hotterbeekx, An, et al.
Publicado: (2020)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation
por: Colebunders, Robert, et al.
Publicado: (2021)

Assessing Onchocerca volvulus Intensity of Infection and Genetic Diversity Using Mitochondrial Genome Sequencing of Single Microfilariae Obtained before and after Ivermectin Treatment
por: Hedtke, Shannon M., et al.
Publicado: (2023)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
por: Mandro, Michel, et al.
Publicado: (2018)

Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania
por: Bhwana, Dan, et al.
Publicado: (2022)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
por: Mukendi, Deby, et al.
Publicado: (2019)

Procedure for Handling and Storage of Onchocerca volvulus Microfilariae Obtained from Skin Snips for Downstream Genetic Work
por: Hedtke, Shannon M., et al.
Publicado: (2023)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus
por: Osei-Atweneboana, Mike Y., et al.
Publicado: (2011)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
por: Mandro, Michel, et al.
Publicado: (2020)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Genetic Selection of Low Fertile Onchocerca volvulus by Ivermectin Treatment
por: Bourguinat, Catherine, et al.
Publicado: (2007)

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis
por: Lustigman, Sara, et al.
Publicado: (2007)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor
por: Amaral, Luís-Jorge, et al.
Publicado: (2023)

Neurological manifestations in Onchocerca volvulus infection: A review
por: Hotterbeekx, An, et al.
Publicado: (2019)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2021)

The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey
por: Jada, Stephen Raimon, et al.
Publicado: (2022)

High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey
por: Raimon, Stephen, et al.
Publicado: (2021)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
por: Mandro, Michel, et al.
Publicado: (2020)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Reproductive Status of Onchocerca volvulus after Ivermectin Treatment in an Ivermectin-Naïve and a Frequently Treated Population from Cameroon
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2014)

Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study
por: Bhwana, Dan, et al.
Publicado: (2023)

Dynamics of Onchocerca volvulus Microfilarial Densities after Ivermectin Treatment in an Ivermectin-naïve and a Multiply Treated Population from Cameroon
por: Pion, Sébastien D. S., et al.
Publicado: (2013)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum
por: Hendy, Adam, et al.
Publicado: (2021)

Contribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico
por: Rodríguez-Pérez, Mario A, et al.
Publicado: (2007)

A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection
por: Awadzi, Kwablah, et al.
Publicado: (2014)

Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo
por: Dusabimana, Alfred, et al.
Publicado: (2021)

Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon
por: Senyonjo, Laura, et al.
Publicado: (2016)

A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana
por: Opoku, Nicholas O., et al.
Publicado: (2022)

Molecular cloning of an immunodominant antigen of Onchocerca volvulus
Publicado: (1988)

Interruption of Onchocerca volvulus transmission in Northern Venezuela
por: Convit, Jacinto, et al.
Publicado: (2013)

The genome of Onchocerca volvulus, agent of river blindness
por: Cotton, James A., et al.
Publicado: (2016)

Onchocerca volvulus Mimicking Metastatic Breast Carcinoma
por: Nava, Victor E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l5um4vnghda6j0474r347l1qb5